Present scholarly interests include: Clinical development of new pharmaceutical agents in multiple therapeutic areas, pharmaceutical industry trends, key opinion leader identification and management. Also, the design and implementation of disease management initiatives focused on modifying patient behavior, value assessments, and outcomes studies evaluating the benefits of interventions on patient care.
